title: Combination pharmacotherapy for stopping smoking: what advantages does it offer?
abstract: Globally, tobacco kills almost 5 million people around the world annually. Seven first-line pharmacotherapies are currently available and recommended by the United States Public Health Service (USPHS) clinical practice guideline for treating tobacco dependence, all of which have been proven to be effective for increasing tobacco abstinence rates when used as monotherapy. However, not all smokers are able to quit with single-drug therapy. Some smokers may benefit from combination therapy that includes the simultaneous use of different nicotine replacement therapies (NRTs) or medications with different mechanisms of action (e.g. NRT and bupropion). Combination therapy with different types of NRT may provide a therapeutic advantage by increasing serum nicotine concentrations, and combination therapy with different drugs may capitalize on synergy obtained from two different mechanisms of action. However, controversy exists regarding this approach. Available data suggests that combination therapy may increase abstinence rates compared with monotherapy. However, the cost effectiveness of this approach has not been clearly demonstrated.
authors.affiliation: Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. ebbert.jon@mayo.edu
authors.forename: Jon O
authors.initials: JO
authors.lastname: Ebbert
authors.forename: J Taylor
authors.initials: JT
authors.lastname: Hays
authors.forename: Richard D
authors.initials: RD
authors.lastname: Hurt
mesh_terms: D000818:Animals; D016642:Bupropion / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000031:analogs & derivatives; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012907:Smoking / Q000188:drug therapy* / Q000378:metabolism; D016540:Smoking Cessation / Q000379:methods*
chemical_list: D016642:Bupropion; D009538:Nicotine
references.citation: Biol Psychiatry. 2008 Jun 1;63(11):1092-6
references.pmid: 18096137
references.citation: N Engl J Med. 1997 Oct 23;337(17):1195-202
references.pmid: 9337378
references.citation: Tob Control. 2006 Jun;15(3):152-9
references.pmid: 16728744
references.citation: Arch Gen Psychiatry. 2009 Nov;66(11):1253-62
references.pmid: 19884613
references.citation: J Clin Psychopharmacol. 2007 Aug;27(4):380-6
references.pmid: 17632223
references.citation: JAMA. 2006 Jul 5;296(1):56-63
references.pmid: 16820547
references.citation: JAMA. 2006 Jul 5;296(1):47-55
references.pmid: 16820546
references.citation: Trends Pharmacol Sci. 1992 May;13(5):177-84
references.pmid: 1604710
references.citation: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103
references.pmid: 18646137
references.citation: Arch Intern Med. 2009 Dec 14;169(22):2148-55
references.pmid: 20008701
references.citation: BMJ. 2008 May 31;336(7655):1223-7
references.pmid: 18441375
references.citation: Ann Intern Med. 2010 Feb 2;152(3):144-51
references.pmid: 20124230
references.citation: Drug Alcohol Depend. 2006 Apr 28;82(2):91-102
references.pmid: 16188401
references.citation: J Clin Pharmacol. 2006 Dec;46(12):1439-48
references.pmid: 17101743
references.citation: N Engl J Med. 1999 Mar 4;340(9):685-91
references.pmid: 10053177
references.citation: J Thorac Oncol. 2007 Mar;2(3):249-56
references.pmid: 17410050
references.citation: BMJ. 1999 Jan 30;318(7179):285-8
references.pmid: 9924052
references.citation: Nicotine Tob Res. 2009 Mar;11(3):234-9
references.pmid: 19246427
references.citation: Nicotine Tob Res. 2009 May;11(5):572-6
references.pmid: 19351781
references.citation: Alcohol. 2007 Aug;41(5):381-91
references.pmid: 17889314
references.citation: Arch Intern Med. 1999 Sep 27;159(17):2033-8
references.pmid: 10510989
references.citation: Nicotine Tob Res. 2003 Apr;5(2):181-7
references.pmid: 12745490
references.citation: CNS Drugs. 2001;15(6):453-67
references.pmid: 11524024
references.citation: Psychopharmacology (Berl). 2007 Feb;190(2):157-70
references.pmid: 17115136
references.citation: Thorax. 2008 Aug;63(8):717-24
references.pmid: 18263663
references.citation: Prev Med. 1995 Jan;24(1):41-7
references.pmid: 7740014
references.citation: Arch Intern Med. 2004 Nov 8;164(20):2229-33
references.pmid: 15534159
references.citation: Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S26-37
references.pmid: 12369228
references.citation: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146
references.pmid: 18253970
references.citation: Mayo Clin Proc. 2007 Feb;82(2):186-95
references.pmid: 17290726
references.citation: Arch Intern Med. 2000 Nov 13;160(20):3128-34
references.pmid: 11074742
references.citation: Addiction. 2008 Jan;103(1):146-54
references.pmid: 18028247
references.citation: Psychopharmacology (Berl). 1993;111(3):271-7
references.pmid: 7870963
references.citation: Ann Intern Med. 2009 Apr 7;150(7):447-54
references.pmid: 19349630
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031
references.pmid: 17253443